Videos

Dr. Meghnath Dhimal, Chief Research Officer of the Nepal Health Research Council, discusses the how the council and Ministry of Health & Population utilizes Global Burden of Disease Study data and information.

Congratulations to Kristin Braa & Jørn Braa on being awarded the 2020 Roux Prize for turning evidence into health impact! 

Dr. Mathilde Touvier, Head of the Nutritional Epidemiology Research at Sorbonne Paris Nord University, shares how the Global Burden of Disease study allows her research team to "efficiently improve nutritional prevention of chronic diseases."

Dr. Nafsiah Mboi, Minister of Health of Indonesia 2012-2014 and IHME Board Member, is a pediatrician and public health expert. She says that, "open access to the GBD data, and tools for analysis on the IHME website, has increased the number of people making use of data-based analysis and policy development for public health.

Professor John Newton, Director of Health Improvement at Public Health England, describes how the agency regularly provides insights and ideas to the annual Global Burden of Disease Study, and uses information from the study to influence health policy.

Professor Shuhei Nomura of the Department of Health Policy and Management at Keio University in Japan shares how he uses Global Burden of Disease Study data to advance health policy for prefectures, nationwide nutrition, and resource allocation.

Dr. Cristiana Abbafati is a health economist at the University of Sapienza in Rome and a collaborator with the Global Burden of Disease Study. She utilizes GBD resources to better understand the relationship between Type II Diabetes, healthcare costs, and developmental levels in EU countries in order to recommend future health policies.

Professor Peter Keiyoro of the University of Nairobi in Kenya, a collaborator of the Global Burden of Disease Study for six years, describes how the GBD has guided the Kenyan government into a national universal health coverage program. Additionally, GBD data laid the foundation for the Kenyan government to launch a pilot program that addresses water availability, sanitation, nutrition, child hygiene, under-five mortality, maternal health, and insurance coverage and health policies.

Global Burden of Disease Study, convened by the Institute for Health Metrics and Evaluation, is the most comprehensive global health study to date. It analyzes 286 causes of death, 369 diseases and injuries, and 87 risk factors in 204 countries and territories.

Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, introduces the Global Burden of Disease Study 2019.

El director de IHME y principal modelador de COVID-19, el Dr. Christopher J.L. Murray, explica qué es la inmunidad colectiva y por qué es poco probable que las comunidades hayan alcanzado la inmunidad colectiva, y ciertamente no se ha alcanzado en los Estados Unidos ni en Europa. 

Herd immunity is not an effective strategy for addressing the COVID-19 pandemic. IHME Director and lead COVID-19 modeler Dr. Christopher Murray busts myths about the strategy and provides insights on more effective solutions to the global crisis.

Dr. Christopher J.L. Murray discusses key assumptions behind our COVID-19 model's forecast of a winter surge in COVID-19 deaths: seasonality and declining vigilance with mask-wearing and social distancing.

IHME Director Dr. Christopher J.L. Murray discusses a key assumption in IHME's COVID-19 model as of September 3, 2020 — seasonality.

Universal health coverage is defined as all people receiving quality health services without incurring financial hardship. The paper, part of the Global Burden of Disease study, was published today in the international medical journal The Lancet. Researchers focused only on measuring service coverage, developing a new framework to capture how well countries align health services with the needs of the population and how well or poorly those services contribute to people’s health.